Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2008-01-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives:
This is a small trial evaluating the efficacy of social cognition interaction training (SCIT) an experimental behavioral treatment for improving social cognition in schizophrenia.
Research Design and Methodology:
Approximately 48 participants with schizophrenia-spectrum disorders will be randomized into one of two conditions: 1) a 20 to 24 session manualized social cognition interaction training group (SCIT), or 2) wait-list control. Pre-and post-group therapy assessments of symptoms, social cognition, basic cognition, and community function will be conducted. Data obtained from this study will allow us to determine the efficacy of SCIT training in improving symptom, cognitive, and functional measures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social Cognition Intervention
NCT01267019
Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia
NCT00601224
Cognitive Training and Enhanced Supported Employment in Schizophrenia
NCT00339170
Efficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in Patients With Schizophrenia
NCT05130853
Cognitive Training for Patients With Schizophrenia
NCT01521026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 Social Cognition Interaction Training
Will receive 20-26 sessions of a manualized group treatment called Social Cognition Interaction Training
Social Cognition Interaction Training
manualized group therapy
2 Wait List Control
Wait list control; 6 months of treatment as usual followed by Social Cognition Interaction Training group
WLC
wait-list control for 6 months, followed by the experimental group therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Social Cognition Interaction Training
manualized group therapy
WLC
wait-list control for 6 months, followed by the experimental group therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 65
* minimum of 30 days since discharge from last hospitalization
* minimum of 30 days since last change in psychiatric medications
* no housing changes in the past 30 days
Exclusion Criteria
* history of brain trauma or neurological disease
* mental retardation or developmental disability
* auditory or visual impairment that would interfere with study procedures
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Connecticut Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanna Fiszdon, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
VA Connecticut Heathcare System and Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Connecticut Mental Health Center
New Haven, Connecticut, United States
VA Connecticut Healthcare System
West Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fiszdon JM, Dixon HD, Davidson CA, Roberts DL, Penn DL, Bell MD. Efficacy of social cognition and interaction training in outpatients with schizophrenia spectrum disorders: randomized controlled trial. Front Psychiatry. 2023 Aug 4;14:1217735. doi: 10.3389/fpsyt.2023.1217735. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D4628W
Identifier Type: -
Identifier Source: secondary_id
JMF0005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.